Showing results (51-60 of 72) with videos related to
Sort By:
Pageof 8
Blood|March 17, 2024
An international learning collaborative phase 2 trial for haploidentical bone marrow transplant in sickle cell diseaseAdetola A Kassim, Josu de la Fuente, Erfan Nur, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 13, 2018
Treosulfan, Fludarabine, and Low-Dose Total Body Irradiation for Children and Young Adults with Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Allogeneic Hematopoietic Cell Transplantation: Prospective Phase II Trial of the Pediatric Blood and Marrow Transplant ConsortiumEneida R Nemecek, Ralf A Hilger, Alexia Adams, et al.Blood Advances|May 2, 2025
Eltrombopag in combination with immunosuppressive therapy in pediatric severe aplastic anemia: Phase 2 ESCALATE trialAkiko Shimamura, Alexey Maschan, Caroyln Bennett, et al.Blood|June 22, 2021
Omidubicel vs standard myeloablative umbilical cord blood transplantation: results of a phase 3 randomized studyMitchell E Horwitz, Patrick J Stiff, Corey Cutler, et al.Journal of Clinical Immunology|August 22, 2017
Detection of Sp110 by Flow Cytometry and Application to Screening Patients for Veno-occlusive Disease with ImmunodeficiencyFlorian A Marquardsen, Fabian Baldin, Florian Wunderer, et al.Transplantation and Cellular Therapy|August 11, 2021
Influence of Killer Immunoglobulin-Like Receptors and Somatic Mutations on Transplant Outcomes in Acute Myeloid LeukemiaSanghee Hong, Lisa Rybicki, Aiwen Zhang, et al.Blood Advances|November 10, 2021
Hematologic complications with age in Shwachman-Diamond syndromeElissa Furutani, Shanshan Liu, Ashley Galvin, et al.Journal of the National Comprehensive Cancer Network : JNCCN|November 9, 2022
Pediatric Aggressive Mature B-Cell Lymphomas, Version 3.2022, NCCN Clinical Practice Guidelines in OncologyMatthew Barth, Ana C Xavier, Saro Armenian, et al.Blood|August 28, 2014
Nonpermissive HLA-DPB1 mismatch increases mortality after myeloablative unrelated allogeneic hematopoietic cell transplantationJoseph Pidala, Stephanie J Lee, Kwang Woo Ahn, et al.Blood Advances|April 12, 2023
Alemtuzumab and CXCL9 levels predict likelihood of sustained engraftment after reduced-intensity conditioning HCTAshley V Geerlinks, Brooks Scull, Christa Krupski, et al.Pageof 8